Ann: Osteopore added to Singapore Ministry of Health subsidy list, page-8

Please. See my reply to your mate. Its a stock thread for open discussion on stocks. I make comment on the company and its developments/business vs its valuation (less so on over valued stocks as you get lynched on threads). Refute with objective debate on the company instead of your "fool and his money" insults, or at least go and look at some other bio-techs (noting the price where I began commenting) I have clearly been on (and you can add PAR from a low entry point) if you insist on maligning the poster. I will always tend to argue with people like you whose simplistic argument is to look at a falling past share price graph and come on HC with your Harry Hindsight arguments and observations that are already (overly) baked into the price, just as many were with MSB when all were crying doom and gloom on its $0.30 capital raise and pending death roll, whilst others of us were buying in avidly at such low valuation, with a very healthy realisation of the still very overt real risks for MSB, just as OSX very obvious risks are very clear thanks.

If you are "years out of this stock" you obviously bought OSX at vastly higher valuation - but yet I am the "fool"?

That's the whole point of valuation investing, buying when people like you are stating the obvious doom and gloom, and similarly selling when others do likewise in stupid exuberance. Three stocks where you will find my initial starting commentaries (i.e.) buy in levels, far lower thanks for you and your mates attempts at rubbishing me:


Very good chance probability OSX DOES NOT replicate them...but also probability with time, it does.